Clinical Trials

For more information on any Aerpio clinical trial please click the corresponding link below:

TIME-2b Study: A Phase 2 Study of AKB-9778 in Patients with Non-Proliferative Diabetic Retinopathy

https://clinicaltrials.gov/ct2/show/NCT03197870?term=TIME-2b&rank=1


TIME-2 Study: A Phase 2 Study of AKB-9778, a Novel Tie-2 Activator, in Patients with Diabetic Macular Edema (TIME-2)

https://clinicaltrials.gov/ct2/show/NCT02050828?term=akb9778&rank=3


TIME-1 Study: Safety and Pilot Efficacy of AKB-9778 in Subjects with Diabetic Macular Edema

https://clinicaltrials.gov/ct2/show/NCT01702441?term=akb9778&rank=2


TEVO Study: Open Label Study to Assess the Efficacy and Safety of AKB-9778 in Subjects with Macular Edema Due to RVO

https://clinicaltrials.gov/ct2/show/NCT02387788?term=aerpio&rank=3


Study to Assess the Absorption, Metabolism, Excretion and Pharmacokinetics of [14C]-AKB-9778

https://clinicaltrials.gov/ct2/show/NCT02858271?term=aerpio&rank=1


Single Ascending Dose Study to Assess the Safety, Tolerability, PK and PD Effects of AKB-4924 in Male Volunteers

https://clinicaltrials.gov/ct2/show/NCT02914262?term=aerpio&rank=4